Innovus Pharmaceuticals

INNV59

Insider Stock

$5.36arrow_drop_up1.13%$0.06

Insider Stock

INNV59

$5.36

arrow_drop_up1.13%$0.06

Insider Stock

Performance History

Key Stats
Open	$5.92
Prev. Close	$5.97
EPS	-0.12
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	5.79	5.93
52 Week Range	3.52	6.73

Ratios







EPS	-0.12

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Innovus Pharmaceuticals (INNV)

Innovus Pharmaceuticals, Inc. (INNV) is a pharmaceutical company that focuses on the development and commercialization of over-the-counter (OTC) and consumer health products. The company's mission is to improve the health and well-being of individuals by providing innovative and accessible healthcare solutions. With a diverse portfolio of products, Innovus aims to address a wide range of medical conditions and help patients live healthier lives.

One of the key strengths of Innovus Pharmaceuticals is its strong market presence. The company has established itself as a leader in the OTC and consumer health product market, with a wide distribution network that spans across multiple channels. This enables Innovus to reach a large customer base and generate significant sales. Additionally, the company continually invests in marketing and promotional activities to build brand awareness and drive demand for its products.

Websitecall_made

Sector: Healthcare
Industry: Medical Care Facilities
CEO: Mr. Patrick Blair
Headquarters: Denver
Employees: 2000
Exchange: NASDAQ

add Innovus Pharmaceuticals to watchlist

Keep an eye on Innovus Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Innovus Pharmaceuticals's (INNV) price per share?

The current price per share for Innovus Pharmaceuticals (INNV) is $5.36. The stock has seen a price change of $0.06 recently, indicating a 1.13% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Innovus Pharmaceuticals (INNV)?

For Innovus Pharmaceuticals (INNV), the 52-week high is $6.73, which is 25.56% from the current price. The 52-week low is $3.52, the current price is 52.27% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Innovus Pharmaceuticals (INNV) a growth stock?

Innovus Pharmaceuticals (INNV) has shown an average price growth of -4.94% over the past three years. It has received a score of 26 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Innovus Pharmaceuticals as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Innovus Pharmaceuticals (INNV) stock price performance year to date (YTD)?

As of the latest data, Innovus Pharmaceuticals (INNV) has a year-to-date price change of -13.96%. Over the past month, the stock has experienced a price change of -9.76%. Over the last three months, the change has been -9%. Over the past six months, the figure is 33.33%.

help

Is Innovus Pharmaceuticals (INNV) a profitable company?

Innovus Pharmaceuticals (INNV) has a net income of -$23.22M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 17.29% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -2.39% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 11.01%, providing insight into the company's sales performance and growth. The gross profit is $132.06M. Operating income is noted at -$23.18M. Furthermore, the EBITDA is $1.15M.

help

What is the market capitalization of Innovus Pharmaceuticals (INNV)?

Innovus Pharmaceuticals (INNV) has a market capitalization of $723.33M. The average daily trading volume is 5.33, indicating the stock's liquidity and investor engagement.